Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic’s Insulin Delivery Devices

ABBOTT PARK, Ill., Aug. 7, 2024 /PRNewswire/ — Abbott (NYSE: ABT) today announced a unique global partnership with Medtronic to collaborate on an integrated continuous glucose monitoring (CGM) system based on Abbott’s most advanced, world-leading1 FreeStyle Libre technology that will connect with Medtronic’s automated insulin delivery (AID) and smart insulin pen systems. The integration of […] L'articolo Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic’s Insulin Delivery Devices proviene da La Ragione.

CONTINUA A LEGGERE